Henchcliffe, Claire

Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson’s Disease

Schweitzer, J. S., Song, B., Herrington, T. M., Park, T.-Y., Lee, N., Ko, S., Jeon, J., Cha, Y., Kim, K., Li, Q., et al. (2020) · New England Journal of Medicine

Pluripotent Stem Cells ResearchParkinson's Disease Mechanisms and Treatments

Cited by 542

Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease

Tabar, V., Sarva, H., Lozano, A. M., Fasano, A., Kalia, S. K., Yu, K. K. H., Brennan, C., Ma, Y., Peng, S., Eidelberg, D., et al. (2025) · Nature

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 181

Data-driven subtyping of Parkinson's disease using longitudinal clinical records: a cohort study

Zhang, X., Chou, J., Liang, J., Xiao, C., Zhao, Y., Sarva, H., Henchcliffe, C., & Wang, F. (2019) · Scientific Reports

Parkinson's Disease Mechanisms and TreatmentsMachine Learning in Healthcare

Cited by 137